about
Degeneration of dopaminergic mesocortical neurons and activation of compensatory processes induced by a long-term paraquat administration in rats: implications for Parkinson's disease.Modeling tardive dyskinesia: predictive 5-HT2C receptor antagonist treatment.Dopamine D2 agonist priming in intact and dopamine-lesioned rats.8-hydroxy-2'-deoxyguanosine in colorectal adenocarcinoma--is it a result of oxidative stress?Dopamine receptor supersensitivity: development, mechanisms, presentation, and clinical applicability.Fluoride Alteration of [3H]Glucose Uptake in Wistar Rat Brain and Peripheral Tissues.Stereotypic progressions in psychotic behavior.Selective Lifelong Destruction of Brain Monoaminergic Nerves Through Perinatal DSP-4 Treatment.Perinatal 6-Hydroxydopamine Modeling of ADHD.Neonatal DSP-4 treatment modifies antinociceptive effects of the CB1 receptor agonist methanandamide in adult rats.Lesion of the cerebellar noradrenergic innervation enhances the harmaline-induced tremor in rats.Increased reactive oxygen species production in the brain after repeated low-dose pesticide paraquat exposure in rats. A comparison with peripheral tissues.Gestational manganese intoxication and anxiolytic-like effects of diazepam and the 5-HT1A receptor agonist 8-OH-DPAT in male Wistar rats.Thioperamide, an H₃ receptor antagonist prevents [³H]glucose uptake in brain of adult rats lesioned as neonates with 5,7-dihydroxytryptamine.Effect of pre- and postnatal manganese exposure on brain histamine content in a rodent model of Parkinson's disease.Alternating extremely low frequency magnetic field increases turnover of dopamine and serotonin in rat frontal cortex.Neonatal co-lesion by DSP-4 and 5,7-DHT produces adulthood behavioral sensitization to dopamine D(2) receptor agonists.Reactivity of 5-HT1A receptor in adult rats after neonatal noradrenergic neurons' lesion--implications for antidepressant-like action.Neonatal DSP-4 treatment modifies GABAergic neurotransmission in the prefrontal cortex of adult rats.Histamine H(3) receptor ligands modulate L-dopa-evoked behavioral responses and L-dopa derived extracellular dopamine in dopamine-denervated rat striatum.Ontogenetic noradrenergic lesion alters histaminergic activity in adult rats.Perinatal 6-Hydroxydopamine to Produce a Lifelong Model of Severe Parkinson's Disease.A slowly developing dysfunction of dopaminergic nigrostriatal neurons induced by long-term paraquat administration in rats: an animal model of preclinical stages of Parkinson's disease?Effect of prenatal lead exposure on nigrostriatal neurotransmission and hydroxyl radical formation in rat neostriatum: dopaminergic-nitrergic interaction.Effects of Propofol on Oxidative Stress Parameters in Selected Parts of the Brain in a Rat Model of Parkinson Disease.Effects of Propofol on the Liver Oxidative-Antioxidant Balance in a Rat Model of Parkinson's Disease.Impairment in Pain Perception in Adult Rats Lesioned as Neonates with 5.7-Dihydroxytryptamine.Toxic influence of subchronic paraquat administration on dopaminergic neurons in rats.Decreased behavioral response to intranigrally administered GABAA agonist muscimol in the lactacystin model of Parkinson's disease may result from partial lesion of nigral non-dopamine neurons: comparison to the classical neurotoxin 6-OHDA.The effect of central noradrenergic system lesion on dopamine (DA) and serotonin (5-HT) synthesis rate following administration of 5-HT3 receptor ligands in chosen parts of the rat brain.Histamine H3 receptor agonist- and antagonist-evoked vacuous chewing movements in 6-OHDA-lesioned rats occurs in an absence of change in microdialysate dopamine levels.6-OHDA injections into A8-A9 dopaminergic neurons modelling early stages of Parkinson's disease increase the harmaline-induced tremor in rats.Desensitization of 5-HT(1A) autoreceptors induced by neonatal DSP-4 treatment.DSP-4 prevents dopamine receptor priming by quinpirole.Association between chemotherapy and plasma adipokines in patients with colorectal cancer.Perinatal Treatments with the Dopamine D₂-Receptor Agonist Quinpirole Produces Permanent D₂-Receptor Supersensitization: a Model of Schizophrenia.7-OH-DPAT, unlike quinpirole, does not prime a yawning response in ratsOntogenetic exposure of rats to pre- and post-natal manganese enhances behavioral impairments produced by perinatal 6-hydroxydopamineOntogenetic serotoninergic lesioning alters histaminergic activity in rats in adulthood[Comparison of exposure to stress and analysis of ways of coping with stress among freight transport and public transport drivers]
P50
Q34541492-7FAE1899-1AB0-4CEF-A7A4-2A7914AE3812Q34621322-8153EEF4-2188-4822-8145-FB67884C6245Q36003804-0018B04E-0489-4716-AE78-8F0077642E13Q37115954-7AC9D9F2-A7C2-47D9-8F35-82C3FE34E1B0Q37346459-A26DDFBF-F445-439A-B4E3-B58CF81FB8AEQ37714574-88048692-05BF-4220-A225-3632EB7D529BQ37735755-CEC4A2C3-A284-4A45-98B7-A896824F2728Q38597060-70FF5792-088D-48F0-B307-613CF2FCA2DFQ38609428-EDC271CD-653B-4D60-AC43-B1B95DA2AB3BQ42108639-7A33C2E2-2A65-4A06-B1BE-4754206F41D2Q42755700-F8DFD793-9C0D-4A67-8893-7343610B0CCCQ43108855-9BC883DE-042C-4D5E-8F07-77490AD5DE84Q43191769-B9DE263D-EA74-4FCA-884A-17ED62047A4CQ44082817-30FE2D2A-D94B-43CC-8073-4623E5FD9980Q44782507-C68C1964-1A46-4AC9-8FB8-9741B881D71FQ45011022-31A14438-3F2B-4A49-B17B-3528E9F9F682Q46011226-02A3DA79-CB35-462C-B34D-237D6B9F7A9AQ46369617-7B70BAAA-017C-4AF8-8252-2D5E93F1252FQ46560351-0341DA4A-B86C-4B07-8C19-E84F3FACDBB6Q46560355-0513E5F1-3D76-4B33-8BB9-633AB8C892E3Q46565305-81863A95-C1E1-44C3-AB4C-9B0832BCBB69Q46652882-F3E098F7-AF9C-4E7C-A03D-AB6134DA4C8CQ46725802-54C1F9B0-307A-4420-95B0-AD27FAE85DF3Q46748684-53610021-62FD-49DA-8C50-2D0EDFC89273Q47340282-29269F2F-5D1E-4877-A009-B8870727CDE2Q47348363-757A1B19-0CAA-497C-8171-826C75BAD974Q48072581-01D95A2F-A099-45F0-B1F4-CB3B47C05360Q48172767-9C01ECF9-7C6B-4353-92DE-A00865EFCB36Q48342310-29B78057-8175-4FFE-9952-B9E38EA15536Q48390537-7C36C8E1-766D-47FF-9E1C-4DEE26F407CDQ48390862-24FEEF7E-6CD2-444E-90A8-A720131D4A25Q48405663-03A5B93C-E386-4FE9-9353-F213117C9BDEQ48552349-26D5B28F-DD0C-41A7-8AE0-794772422629Q48555410-9690738C-1705-4358-9302-C36E18301D79Q51118521-9785E482-9BDA-4F40-95DF-A6389065B2FFQ52147043-826D8658-6800-4B9D-80F2-2085395888FCQ73289653-F21DBE9E-E206-4C8F-BC50-7CA5FA663A27Q84006345-12C65174-6D57-4844-A493-216B86AA8376Q85025991-3942691B-61A7-404D-AFC1-87CE76AEE19EQ88323661-5D1CD383-F77B-44B3-9D07-D8138485A498
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Przemyslaw Nowak
@ast
Przemyslaw Nowak
@en
Przemyslaw Nowak
@es
Przemyslaw Nowak
@nl
type
label
Przemyslaw Nowak
@ast
Przemyslaw Nowak
@en
Przemyslaw Nowak
@es
Przemyslaw Nowak
@nl
prefLabel
Przemyslaw Nowak
@ast
Przemyslaw Nowak
@en
Przemyslaw Nowak
@es
Przemyslaw Nowak
@nl
P108
P106
P1153
7102475908
P31
P496
0000-0002-0269-5382